Ranolazin: mechanism of antianginal effects [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2016; 44(3): 8-12 | DOI: 10.5543/tkda.2016.72626

Ranolazin: mechanism of antianginal effects

Murat Özdemir
Gazi Üniversitesi Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Ankara

Ranolazin is indicated for the control of angina in patients with chronic stable coronary artery disease. Born as a “metabolic modulator”, ranolazine is now considered to be a “late sodium current blocker”. This review tries to summarize the mechanism of antianginal effects of ranolazine.

How to cite this article
Murat Özdemir. Ranolazin: mechanism of antianginal effects. Turk Kardiyol Dern Ars. 2016; 44(3): 8-12

Corresponding Author: Murat Özdemir, Türkiye
© Copyright 2020 Archives of the Turkish Society of Cardiology
LookUs & Online Makale